Checkpoint Therapeutics
Why Robinhood?
You can watch CKPT and buy or sell other stocks, ETFs, and their options commission-free!About CKPT
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX.
CKPT Key Statistics
Stock Snapshot
With a market cap of 370.71M, Checkpoint Therapeutics(CKPT) trades at $4.26. The stock has a price-to-earnings ratio of -3.78.
On 2026-09-08, Checkpoint Therapeutics(CKPT) stock opened at —, reached a high of —, and a low of —.
The Checkpoint Therapeutics(CKPT)'s current trading volume is 0, compared to an average daily volume of 2.9M.
During the past year, Checkpoint Therapeutics(CKPT) stock moved between $1.80 at its lowest and $4.50 at its peak.
During the past year, Checkpoint Therapeutics(CKPT) stock moved between $1.80 at its lowest and $4.50 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.